| N(6)-Acetimidoyl-L-lysine | IC50 | 17500.0 [1] |
| Tilarginine | IC50 | 950.0 [1] |
| Tilarginine | Ki | 840.0 [1] |
| Nitroarginine | IC50 | 80.0 [1], 500.0 [2], 4400.0 [3] |
| Nitroarginine | Ki | 15.0 [1], 500.0 [2] |
| L-Homocysteine, S-(2-((1-iminoethyl)amino)ethyl)- | IC50 | 8400.0 [1], 18000.0 [2], 144543.98 [3], 145000.0 [4] |
| 1-(6-Cyano-3-pyridylcarbonyl)-5',8'-difluorospiro[piperidine-4,2'(1'H)-quinazoline]-4'-amine | IC50 | 740.0 [1], 741.31 [2], 790.0 [3], 840.0 [4], 1000.0 [5] |
| 2-Amino-4-methylpyridine | IC50 | 40.0 [1], 75.0 [2], 110.0 [3], 160.0 [4] |
| L-Name | IC50 | 150.0 [1], 1600.0 [2] |
| Aminoguanidine | IC50 | 5900.0 [1], 118000.0 [2] |
| Aminoguanidine | Ki | 3300.0 [1] |
| 7-Nitroindazole | IC50 | 710.0 [1], 2500.0 [2], 2870.0 [3] |
| n5-Iminoethyl-l-ornithine | IC50 | 9000.0 [1] |
| n5-Iminoethyl-l-ornithine | Ki | 230.0 [1], 1700.0 [2] |
| L-N(omega)-Nitroarginine-2,4-L-diaminobutyric amide | Ki | 0.3 [1], 130.0 [2] |
| N'-[(3S,4S)-4-[(6-Amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl]-N-[2-(3-fluorophenyl)ethyl]ethane-1,2-diamine | IC50 | 10000.0 [1] |
| N'-[(3S,4S)-4-[(6-Amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl]-N-[2-(3-fluorophenyl)ethyl]ethane-1,2-diamine | Ki | 52.0 [1], 70.0 [2] |
| Piperidin-2-imine | IC50 | 240.0 [1], 1100.0 [2] |
| 8-Chloro-2,3,3a,9b-tetrahydro-1H-cyclopenta[c]quinolin-4-ylamine | IC50 | 140.0 [1] |
| 4-Methyl-6-propylpyridin-2-amine | IC50 | 10.0 [1], 23.0 [2], 90.0 [3] |
| N'-[(3R,4R)-4-[(6-Amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl]-N-[2-(3-fluorophenyl)ethyl]ethane-1,2-diamine | IC50 | 10000.0 [1] |
| N'-[(3R,4R)-4-[(6-Amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl]-N-[2-(3-fluorophenyl)ethyl]ethane-1,2-diamine | Ki | 5.3 [1], 14.0 [2] |
| 2,3,3a,9b-Tetrahydro-1H-cyclopenta[c]quinolin-4-ylamine | IC50 | 160.0 [1] |
| alpha-[4-[4-(6-Amino-2-pyridinyl)phenethyl]piperazino]acetophenone | IC50 | 140.0 [1] |
| 6-[[4-[2-[2-(3-Fluorophenyl)ethylamino]ethoxy]pyrrolidin-3-yl]methyl]-4-methylpyridin-2-amine | IC50 | 600.0 [1], 700.0 [2], 9000.0 [3] |
| 7-[2-[2-(3-Chlorophenyl)ethylamino]ethyl]quinolin-2-Amine | Ki | 440.0 [1] |
| 7-[2-[2-(3-Fluorophenyl)ethylamino]ethyl]quinolin-2-Amine | Ki | 318.0 [1] |
| 2-Aminopyridine | IC50 | 4800.0 [1], 7200.0 [2] |
| N2-Methyl-L-arginine | IC50 | 950.0 [1], 4300.0 [2] |
| 2-Aminothiazoline | IC50 | 1800.0 [1] |
| 2-Aminothiazoline | Ki | 410.0 [1] |
| delta-N-Methylarginine | IC50 | 10000.0 [1], 10000000.0 [2] |
| 2-Amino-4,6-dimethylpyridine | IC50 | 98.0 [1], 100.0 [2] |
| Methylarginine | IC50 | 90.0 [1], 890.0 [2] |
| L-N(omega)-Nitroarginine-(4R)-amino-L-proline amide | Ki | 0.1 [1], 100.0 [2] |
| (2S)-5-Amino-2-[[(2S)-2-amino-5-[[amino(nitramido)methylidene]amino]pentanoyl]amino]pentanamide;2,2,2-trifluoroacetic acid | Ki | 330.0 [1] |
| Ethyl 4-[(4-methylpyridin-2-yl)amino]piperidine-1-carboxylate | IC50 | 20000.0 [1], 21000.0 [2] |
| Ethyl 4-[(4-methoxypyridin-2-yl)amino]piperidine-1-carboxylate | IC50 | 30000.0 [1], 32000.0 [2] |
| 3,4-Dihydro-2H-pyrrol-5-amine | IC50 | 9600.0 [1], 20000.0 [2] |
| N-(3-Aminomethyl-phenyl)-acetamidine | IC50 | 40.0 [1] |
| N-(3-Aminomethyl-phenyl)-acetamidine | Ki | 40.0 [1] |
| 2-Amino-3,4-dihydroquinoline | IC50 | 4900.0 [1], 28000.0 [2] |
| 6-[4-(2-Dimethylamino-ethoxy)-5,6,7,8-tetrahydro-naphthalen-1-yl]-pyridin-2-ylamine | IC50 | 70.0 [1], 70.9 [2] |
| N',N'-Dibenzyl-6-(4-methoxyphenyl)pteridine-2,4-diamine | IC50 | 4000.0 [1], 34720.0 [2] |
| 4-Methyl-6-(2-(5-(3-(Methylamino)propyl)pyridin-3-Yl)ethyl)pyridin-2-Amine | IC50 | 91.0 [1] |
| 4-Methyl-6-(2-(5-(3-(Methylamino)propyl)pyridin-3-Yl)ethyl)pyridin-2-Amine | Ki | 13.0 [1] |
| 4-Methyl-3,4,5,6-tetrahydropyridin-2-amine | IC50 | 16.0 [1], 200.0 [2] |
| 4-Aminotetrahydrobiopterin | IC50 | 1260.0 [1], 9000.0 [2] |
| 4-({4-[(4-Methoxypyridin-2-Yl)amino]piperidin-1-Yl}carbonyl)benzonitrile | IC50 | 6000.0 [1], 6600.0 [2] |
| 4-N,4-N-Dibenzyl-6-phenylpteridine-2,4-diamine | IC50 | 3000.0 [1], 129300.0 [2] |
| 6-Isobutyl-4-methylpyridin-2-amine | IC50 | 100.0 [1] |
| 6-Fluoro-2,3,3a,9b-tetrahydro-1H-cyclopenta[c]quinolin-4-ylamine | IC50 | 170.0 [1] |
| Azocan-(2Z)-ylideneamine | IC50 | 10000.0 [1], 10150.0 [2] |
| 6-(4-Chlorophenyl)-4-piperidin-1-yl-5,6,7,8-tetrahydropteridin-2-amine | IC50 | 10560.0 [1], 13000.0 [2] |
| 6-(4-Methoxyphenyl)-4-N,4-N-dipropyl-5,6,7,8-tetrahydropteridine-2,4-diamine | IC50 | 9280.0 [1], 34000.0 [2] |
| 2-Amino-6-methylaminomethyl-5,6,7,8-tetrahydro-3H-pteridin-4-one | IC50 | 3900.0 [1], 20000.0 [2] |
| 3-Amino-1-hydroxy-5,6,6a,7-tetrahydro[1,3]oxazolo[3,4-f]pteridin-9-one | IC50 | 22350.0 [1], 40000.0 [2] |
| 2-Amino-4-hydroxy-6-(4-fluorophenyl)pteridine | IC50 | 8000.0 [1], 65510.0 [2] |
| N-[5-(1-Benzylpyridin-1-ium-3-carbonyl)-4-oxo-6,7-diphenyl-3,6,7,8-tetrahydropteridin-2-yl]-2-methylpropanamide | IC50 | 16000.0 [1], 111100.0 [2] |
| 2-Amino-5-benzoyl-5,6,7,8-tetrahydro-3H-pteridin-4-one | IC50 | 90000.0 [1], 500000.0 [2] |
| 5-Iminohexahydro-1,4-thiazepine | IC50 | 4300.0 [1], 6800.0 [2] |
| 5-Iminohexahydro-1,4-oxazepine | IC50 | 8700.0 [1], 17740.0 [2] |
| N'-[(3S,4S)-4-[(6-Amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl]-N-[(4-chlorophenyl)methyl]ethane-1,2-diamine | Ki | 0.09 [1], 85.0 [2] |
| 8-Chloro-6-fluoro-2,3,3a,9b-tetrahydro-1H-cyclopenta[c]quinolin-4-ylamine | IC50 | 290.0 [1], 730.0 [2] |
| 6,7-Difluoro-2,3,3a,9b-tetrahydro-1H-cyclopenta[c]quinolin-4-ylamine | IC50 | 680.0 [1] |
| Methyl (2R)-5-[[amino(nitramido)methylidene]amino]-2-[[(2R)-2-amino-3-phenylpropanoyl]amino]pentanoate;2,2,2-trifluoroacetic acid | Ki | 2000.0 [1], 400000.0 [2] |
| N'-[3-(1-Methyl-3,6-dihydro-2H-pyridin-4-yl)-1H-indol-6-yl]thiophene-2-carboximidamide;dihydrochloride | IC50 | 800.0 [1] |
| N'-[1-[4-(Methylamino)cyclohexyl]-2,3-dihydroindol-6-yl]thiophene-2-carboximidamide | IC50 | 370.0 [1], 2120.0 [2] |
| 7-[2-[2-(3-Fluorophenyl)ethylamino]ethyl]quinolin-2-amine;dihydrochloride | Ki | 318.0 [1] |
| N'-[1-[2-[(2R)-1-Methylpyrrolidin-2-yl]ethyl]indol-6-yl]thiophene-2-carboximidamide;dihydrochloride | IC50 | 320.0 [1] |
| 7-[[4-Chloranyl-3-(Methylaminomethyl)phenoxy]methyl]quinolin-2-Amine | Ki | 295.0 [1] |
| 3,4,5,6-Tetrahydro-2H-azepin-7-amine | IC50 | 3500.0 [1] |
| 6-(4-Chlorophenyl)-4-N,4-N-diethyl-5,6,7,8-tetrahydropteridine-2,4-diamine | IC50 | 8000.0 [1], 13970.0 [2] |
| N-(3-Aminomethyl-phenyl)-furan-2-carboxamidine | Ki | 6.3 [1] |
| 6-(4-Chlorophenyl)-4-N-(cyclohexylmethyl)-5,6,7,8-tetrahydropteridine-2,4-diamine | IC50 | 3680.0 [1], 5000.0 [2] |
| 2-Imino-7-butylhexahydro-1H-azepine | IC50 | 850.0 [1] |
| 3-Methyl-2-propyl-3,4-dihydro-2H-pyrrol-5-amine | IC50 | 390.0 [1], 4800.0 [2] |
| N'-[5-Fluoro-1-[4-(methylamino)cyclohexyl]-2,3-dihydroindol-6-yl]thiophene-2-carboximidamide | IC50 | 5750.0 [1], 5820.0 [2] |
| N'-[3-[4-(Dimethylamino)cyclohexyl]-1H-indol-5-yl]thiophene-2-carboximidamide;hydrochloride | IC50 | 350.0 [1], 4520.0 [2] |
| N'-[3-[4-(Methylamino)cyclohexyl]-1H-indol-5-yl]thiophene-2-carboximidamide;hydrochloride | IC50 | 400.0 [1], 1800.0 [2] |
| N'-[3-[4-(Ethylamino)cyclohexyl]-1H-indol-5-yl]thiophene-2-carboximidamide;hydrochloride | IC50 | 540.0 [1], 7520.0 [2] |
| Imidazole | Ki | 175000.0 [1] |
| Chlorzoxazone | IC50 | 50000.0 [1] |
| Carbamimidothioic acid, 2-aminoethyl ester | Ki | 1800.0 [1] |
| N-(3-(Aminomethyl)benzyl)acetamidine | Ki | 7300.0 [1] |
| Carbamimidothioic acid, methyl ester | Ki | 160.0 [1] |
| 2-Aminothiazole | Ki | 12000.0 [1] |
| Indazole | IC50 | 178000.0 [1] |
| N6-Ethanimidoyl-D-lysine | IC50 | 37000.0 [1] |
| S-Methyl-L-thiocitrulline | IC50 | 60.0 [1] |
| s-Ethylisothiourea | Ki | 29.0 [1] |
| 3-Bromo-7-nitroindazole | IC50 | 170.0 [1] |
| 1400W Dihydrochloride | Ki | 2000.0 [1] |
| 1-Phenylimidazole | Ki | 430000.0 [1] |
| 6-Hydroxymethylpterin | IC50 | 180000.0 [1] |
| 5-Nitroindazole | IC50 | 47000.0 [1] |
| 1-Aminoisoquinoline | IC50 | 6600.0 [1] |
| S,S'-(1,4-Phenylene-bis(1,2-ethanediyl))bis-isothiourea | Ki | 16.0 [1] |
| (2S)-2-Amino-5-(1-aminobut-3-enylideneamino)pentanoic Acid | Ki | 100.0 [1] |
| 2-Amino-3-methylpyridine | IC50 | 1300.0 [1] |